Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
1,533
Total Claims
$1.4M
Drug Cost
277
Beneficiaries
$4,953
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 9,082 Pulmonary Disease providers
-4%
Cost per patient vs peers
$4,953 vs $5,138 avg
+63%
Brand preference vs peers
100.0% vs 61.4% avg
Brand vs Generic
Brand: 881 claims · $1.3M
Generic: 0 claims · $0
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Nintedanib Esylate | 50 | $689K |
| Fluticasone/Umeclidin/Vilanter | 237 | $230K |
| Mepolizumab | 22 | $79K |
| Pirfenidone | 30 | $68K |
| Fluticasone/Vilanterol | 77 | $44K |
| Fluticasone Propion/Salmeterol | 37 | $27K |
| Budesonide/Formoterol Fumarate | 41 | $26K |
| Tiotropium Bromide | 36 | $26K |
| Tiotropium Br/Olodaterol Hcl | 24 | $25K |
| Fluticasone Propion/Salmeterol | 61 | $22K |
| Budesonide/Glycopyr/Formoterol | 18 | $15K |
| Umeclidinium Brm/Vilanterol Tr | 27 | $12K |
| Ipratropium/Albuterol Sulfate | 22 | $12K |
| Albuterol Sulfate | 179 | $7,598 |
| Budesonide/Formoterol Fumarate | 23 | $7,508 |
Prescribing Profile
23
Unique Drugs
3.0
Anomaly Score
Patient Profile
73
Avg Age
63%
Female
1.81
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About